Datafin

Data-driven stock analysis platform for global investors.

Sitemap
HomeScreenerValuationSector Analysis
Resources
LibraryDatafin GuideMetric MethodologyValuation MethodologiesFAQPricingWho Is Datafin?Communication
Legal
Privacy PolicyTerms of UseCookie PolicyKVKK NoticeRefund Policy
Data Sources

Financial data sourced from official regulatory filings and verified market data providers. Metrics calculated using GAAP/IFRS standards.

Disclaimer

The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

Investment decisions involve risk. Verify data independently and consult a licensed advisor when needed.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved.

Last updated: April 2026

ITRI PEER ANALYSIS

Itron Inc — metric-by-metric comparison with peers and the industry median

ITRIItron Inc

🇺🇸 USA · NASDAQ · Technology · Scientific & Technical Instruments

Value itDuel
PriceFinancialsPeers

Overall Profile & Returns

· Scientific & Technical Instruments

Position Within Industry

0 = weak quartile, 100 = strong quartile
ValuationProfitabilityGrowthFinancial Health
ITRIIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year
Split-adjusted
ITRI-36.1%CDA+126.1%HEXA-B-13.3%
Year-to-Date (YTD)
ITRI-6.6%CDA+53.7%HEXA-B-24.6%
1-Year
Split-adjusted
ITRI-36.1%VNT-24.2%BMI-37.6%ST+45.1%NOVT+23.7%ESE+74.9%
Year-to-Date (YTD)
ITRI-6.6%VNT-21.7%BMI-13.6%ST+39.4%NOVT+38.6%ESE+75.4%

Key Metric Comparison

P/E

Lower is better
ITRI13.65CDA61.65HEXA-B9.84Median 44.63

ROE

Higher is better
ITRI18.7%CDA24.3%HEXA-B17.7%Median 9.7%

Net Margin

Higher is better
ITRI12.3%CDA16.9%HEXA-B40.1%Median 12.4%

Revenue Growth

Higher is better
ITRI-4.0%CDA29.1%HEXA-B-6.3%Median 6.5%

P/E

Lower is better
ITRI13.65VNT10.04BMI33.69ST139.56NOVT126.33ESE28.80Median 44.63

ROE

Higher is better
ITRI18.7%VNT35.0%BMI19.6%ST1.7%NOVT5.2%ESE21.5%Median 9.7%

Net Margin

Higher is better
ITRI12.3%VNT13.4%BMI14.6%ST1.3%NOVT5.3%ESE24.7%Median 12.4%

Revenue Growth

Higher is better
ITRI-4.0%VNT4.1%BMI5.2%ST-3.0%NOVT5.6%ESE23.3%Median 6.5%

All Metrics

Valuation
MetricITRICDAHEXA-BInd. Median
P/E13.6561.659.84●44.63
P/B2.4514.211.67●4.89
EV/EBITDA11.8143.646.35●21.25
P/S1.68●10.403.945.11
Financial Health
MetricITRICDAHEXA-BInd. Median
Current Ratio2.661.783.44●1.90
Debt/Equity99.7%33.0%27.1%●32.5%
NetDebt/EBITDA2.170.880.38●0.87
Profitability
MetricITRICDAHEXA-BInd. Median
Net Margin12.3%16.9%40.1%●12.4%
ROE18.7%24.3%●17.7%9.7%
ROA7.7%14.3%●11.4%6.1%
EBITDA Margin17.4%24.3%66.1%●22.2%
Growth + Dividend
MetricITRICDAHEXA-BInd. Median
Rev. Growth-4.0%29.1%●-6.3%6.5%
NI Growth14.3%43.9%108.9%●18.2%
Div. Yield—0.8%●0.2%0.4%
Payout—40.3%19.2%26.9%
Valuation
MetricITRIVNTBMISTNOVTESEInd. Median
P/E13.6510.04●33.69139.56126.3328.8044.63
P/B2.453.296.372.37●5.185.604.89
EV/EBITDA11.818.66●—11.6744.6530.9321.25
P/S1.681.34●4.911.816.757.115.11
Financial Health
MetricITRIVNTBMISTNOVTESEInd. Median
Current Ratio2.661.233.002.753.56●1.451.90
Debt/Equity99.7%154.0%—99.8%22.2%13.4%●32.5%
NetDebt/EBITDA2.172.52—2.88-0.66●0.410.87
Profitability
MetricITRIVNTBMISTNOVTESEInd. Median
Net Margin12.3%13.4%14.6%1.3%5.3%24.7%●12.4%
ROE18.7%35.0%●19.6%1.7%5.2%21.5%9.7%
ROA7.7%9.8%14.0%0.7%3.4%14.6%●6.1%
EBITDA Margin17.4%21.9%22.7%20.6%14.9%23.3%●22.2%
Growth + Dividend
MetricITRIVNTBMISTNOVTESEInd. Median
Rev. Growth-4.0%4.1%5.2%-3.0%5.6%23.3%●6.5%
NI Growth14.3%10.5%-2.7%-60.4%-23.9%161.1%●18.2%
Div. Yield—0.4%1.1%●1.0%—0.1%0.4%
Payout—3.5%34.6%144.5%—2.7%26.9%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on ITRI

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.